Zerong Cai
Sun Yat-sen University
34 Papers
25 Citations
Zerong Cai is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Colorectal cancer & Medicine. The author has an hindex of 9, co-authored 26 publications.
Chat about Author
Papers
Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer
Zhaoliang Yu,Peng Deng,Yufeng Chen,Shini Liu,Jinghong Chen,Zihuan Yang,Jianfeng Chen,Xinjuan Fan,Peili Wang,Zerong Cai,Yali Wang,Peishan Hu,Dezheng Lin,Rong Xiao,Yifeng Zou,Yan Huang,Qiang Yu,Qiang Yu,Ping Lan,Jing Tan,Jing Tan,Xiaojian Wu +21 more
59
MicroRNA 26b promotes colorectal cancer metastasis by downregulating phosphatase and tensin homolog and wingless-type MMTV integration site family member 5A.
Dejun Fan,Xutao Lin,Feng Zhang,Weijie Zhong,Jiancong Hu,Yufeng Chen,Zerong Cai,Yifeng Zou,Xiaowen He,Xiuting Chen,Ping Lan,Xiaojian Wu +11 more
TL;DR: It is reported that ectopic overexpression of microRNA 26b (miR‐26b) in colorectal cancer (CRC) cell lines promoted EMT and stem cell‐like phenotypes in vitro and may represent a therapeutic target for metastatic CRC.
36
Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells
Chuangyu Wen,Junxiong Chen,Di Zhang,Huihui Wang,Jia Che,Qiyuan Qin,Lu He,Zerong Cai,Mengmeng Lin,Qiong Lou,Lanlan Huang,Daici Chen,Aikichi Iwamoto,Donglin Ren,Lei Wang,Ping Lan,Jianping Wang,Huanliang Liu,Xiangling Yang +18 more
TL;DR: Data reveal that PAB induces CRC cell mitotic arrest followed by apoptosis and overcomes 5-FU resistance in vitro and in-vivo, suggesting that P AB may be a potential agent for CRC treatment, particularly for 5-fu-resistant CRC.
34
CCL21 as an independent favorable prognostic factor for stage III/IV colorectal cancer
Yifeng Zou,Yufeng Chen,Xianrui Wu,Ruixue Yuan,Zerong Cai,Xiaosheng He,Xinjuan Fan,Lei Wang,Xiaojian Wu,Ping Lan +9 more
TL;DR: ROC curves showed that CCL21 expression could improve the prognostic capability of TNM stage in stage III/IV CRC patients and was found to be an independent prognostic biomarker for CRC.
Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination
TL;DR: Overexpression of the prognostic and highly mutated antigens ADAMTS18, COL10A1, PPEF1, and STRA6 are potential mRNA vaccine candidates for STAD and patients with IS1 and IS2 are suitable populations for mRNA vaccination immunotherapy.